Rachel Glennerster on why we still don’t have vaccines that could save millions
Rachel Glennerster discusses how market failures and misaligned incentives hinder critical innovations like vaccine development and pandemic preparedness. She explains how market shaping mechanisms, such as advance market commitments, can help overcome these challenges and…